Simultaneous determination of dopa and carbidopa enantiomers by capillary zone electrophoresis

Electrophoresis

Volumn 23, Issue 19, 2002, Pages 3404-3409

  Thi Thanh Ha, Pham ^a   Van Schepdael, Ann ^a   Hauta aho, Tuula ^b   Roets, Eugene ^a   Hoogmartens, Jos ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b ORION CORPORATION   (Finland)

Author keywords

Capillary zone electrophoresis; Carbidopa; Chiral; Cyclodextrin; Dopa; Impurity

Indexed keywords

CAPILLARY ELECTROPHORESIS; CYCLODEXTRINS; DISEASE CONTROL; ENANTIOMERS; FUSED SILICA; SODIUM COMPOUNDS;

CAPILLARY-ZONE ELECTROPHORESIS; CARBIDOPA; CHIRAL; DISEASE TREATMENT; DOPA; DUAL THERAPY; ENANTIOSEPARATIONS; PARKINSON'S DISEASE; SIMULTANEOUS DETERMINATIONS; SINGLE ENANTIOMERS;

IMPURITIES;

CARBIDOPA; CYCLODEXTRIN; DOPA; SILICON DIOXIDE; SODIUM DIHYDROGEN PHOSPHATE; SULFATE;

ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CHIRALITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG IMPURITY; DRUG PURIFICATION; DRUG SAFETY; DRUG STRUCTURE; ELECTRIC POTENTIAL; ENANTIOMER; HUMAN; LINEAR SYSTEM; PARKINSON DISEASE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; CAPILLARY ELECTROPHORESIS; CHEMISTRY; METHODOLOGY; PH; REPRODUCIBILITY; STEREOISOMERISM;

CARBIDOPA; CYCLODEXTRINS; DIHYDROXYPHENYLALANINE; ELECTROPHORESIS, CAPILLARY; HYDROGEN-ION CONCENTRATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM;

EID: 0036709013     PISSN: 01730835     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2683(200210)23:19<3404::AID-ELPS3404>3.0.CO;2-X     Document Type: Article

References (16)

1. Cedarbaum, J. M., Schleifer, L. S., The Pharmacological Basis of Therapeutics, Goodman and Gilman's, Pergamon Press, New York 1990, pp. 463-484.
2. Walbroehl, Y., Wagner, J., J. Chromatogr. A 1994, 685, 321-329.
3. Mori, Y., Ueno, K., Umeda, T., J. Chromatogr. A 1997, 757, 328-332.
4. Gahm, K. H., Stalcup, A. M., Chirality 1996, 8, 316-324.
5. Saraç, S., Chankvetadze, B., Blaschke, G., J. Chromatogr. A 2000, 875, 379-387.
6. Chapman, J., Chen, F. A., LC-GC Europe 2001, Jan, 33-37.
7. Vincent, J. B., Vigh, G., J. Chromatogr. A 1998, 817, 105-111.
8. Dolezalova, M., Tkaczylova, M., Chem. Listy 2000, 94, 994-1002.
9. Dolezalova, M., Fanali, S., Electrophoresis 2000, 21, 3264-3269.
10. Zhang, L., Chen, G., Hu, Q., Fang, Y. Z., Anal. Chim. Acta 2001, 431, 287-292.
11. Gelber, L. R., Neumeyer, J. L., J. Chromatogr. 1983, 257, 317-326.
12. Husain, S., Sekar, R., Rao, R. N., J. Chromatogr. A 1994, 687, 351-355.
13. McMurtrey, K., Strawbridge, C., McCoy, J., Enantiomer 2000, 5, 377-383.
14. Dolezalova, M., Tkaczylova, M., Chirality 1999, 11, 394-403.
15. Dolezalova, M., Tkaczylova, M., J. Pharm. Biomed. Anal. 1999, 19, 555-567.
16. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guidelines, Impurities in Drug Substances (ICH Q3A), http://www.ifpma.org/ich5q.html Oct. 1999, Step 2, 1-10.